Can MRI help tell fibroids from sarcoma?
Part of Cancer clinical trials.
This study uses special MRI scans to improve how doctors tell the difference between benign uterine fibroids and rare uterine sarcomas. It may help avoid unnecessary surgeries or catch cancer earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a uterine mass that might be a fibroid or a rare sarcoma (based on MRI or biopsy).
- You are scheduled for surgery or willing to have long-term checkups.
- You understand the study and agree to join by signing a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses MRI scans to see if a computer can tell the difference between uterine sarcoma (a rare cancer) and fibroids (non-cancerous growths). If you've already been diagnosed with one of these and had an MRI before surgery, you may be able to help.
This study uses AI to look at CT scans from women with uterine sarcomas or fibroids to see if it can tell the difference between the two. The goal is to help doctors make a faster, more accurate diagnosis without needing surgery.
This study uses an artificial intelligence (AI) model to analyze breast MRI images (non-contrast) to help detect breast cancer earlier. It's looking at whether the AI can find signs of cancer without needing a contrast dye injection.
This study tests a new MRI-based technique to better see the size and shape of bone sarcomas before surgery. The goal is to help surgeons remove all the cancer while saving as much healthy bone as possible.
This study uses a special type of MRI called diffusion-weighted imaging (DWI) to look at the endometrium (the lining of the uterus) and help tell the difference between benign and cancerous growths. The results will be compared to a biopsy to see how accurate the MRI is.
This trial uses MRI scans taken before treatment to see if they can predict how well chemo-radiation will work for locally advanced cervical cancer. It aims to help doctors know which patients might benefit most from this therapy.
Hear when a new Uterine Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.